特種原料
大宗尿石素 A 粉末供應商
Urolithin A powder for supplement and functional nutrition product development, with product specifications and batch documentation available to support material review.
產品鑑別
尿石素 A 粉末產品資料
用以指定尿石素 A 粉末原料的核心化學及物理標識。
原料概覽
供配方開發的尿石素 A
Urolithin A is a defined small-molecule metabolite associated with the metabolism of ellagitannins and ellagic acid. As a finished ingredient, it is evaluated as a specific compound rather than as a general botanical extract.
配方背景
Urolithin A has attracted attention in specialty nutrition products, particularly in areas connected with mitochondrial and muscle-related research.
物料審核
For product development, the important considerations are the stated specification, analytical results and the suitability of the powder for the intended formulation.
技術規格
尿石素 A 粉末技術規格
規格限值、檢測方法及相應批次結果已整理於一處，供技術審核。
| 檢測項目 | 規格 | 檢測方法 | 檢測結果 |
|---|---|---|---|
| 物理性質及純度 | |||
| 外觀 | 白色至淺黃色粉末 | 目視 | 淺黃色粉末 |
| 純度 | ≥97% | HPLC | 99.45% |
| 水分 | ≤3% | GB5009.3 | 0.21% |
| 單一雜質 | ≤1.0% | HPLC | 0.35% |
| 有機溶劑 | ≤3000 ppm | GC | N/D |
| 重金屬 | |||
| 鉛（Pb） | ≤0.5 ppm | GB5009.12 | 符合 |
| 汞（Hg） | ≤0.5 ppm | GB5009.17 | 符合 |
| 鎘（Cd） | ≤0.5 ppm | GB5009.15 | 符合 |
| 砷（As） | ≤0.5 ppm | GB5009.11 | 符合 |
| 微生物控制 | |||
| 微生物總數 | ≤500 CFU/g | GB4789.2 | <10 |
| 大腸菌群 | ≤0.92 MPN/g | GB4789.3 | 符合 |
| 黴菌及酵母菌 | ≤50 CFU/g | GB4789.15 | 符合 |
| 金黃色葡萄球菌 | 0/25 g | GB4789.10 | 符合 |
| 茴香胺值 | 0/25 g | GB4789.4 | 符合 |
| 溶解度 | |||
| 溶解度 | 按化驗報告所載 | COA | 可溶於 DMSO；微溶於甲醇及乙醇 |
化驗報告批次
批次資料
與上述化驗報告相應的批次詳情。
應用
尿石素 A 粉末在產品開發中的應用
The powder can be evaluated in different finished-product formats, depending on formulation and manufacturing requirements.
膠囊
Suitable for capsule formulations where the material properties and target active loading fit the product design.
錠劑
Can be evaluated for tablet development according to blending, flow and processing requirements.
粉末配方
Can be considered for powdered products where the physical profile works with the intended formulation process.
機能性食品劑型
Urolithin A has also been evaluated in selected food formats, subject to the requirements of the destination market.
商業確認
為商業採購準備尿石素 A
A practical review should connect the required specification with the sample and the batch intended for production.
主要審核要點
生產路線
The supplied Certificate of Analysis does not state the production route. Where production route is part of the approved specification, confirm it in the applicable technical documentation.
法規說明
目的地市場要求
法規要求取決於預定用途及目的地市場。
美國
FDA GRAS Notice 791 records an FDA “no questions” response for Urolithin A under the conditions of use described in the notification.
英國
The UK Food Standards Agency currently lists RP-1777 for Urolithin A as a novel food application with risk assessment in progress.
儲存
儲存及保質期
儲存資料依所提供化驗報告為準。
儲存條件
存放於陰涼乾燥處，避免強光及高溫。
保質期
所提供化驗報告載明保質期為 2 年。
原料供應查詢
洽談您的尿石素 A 大宗需求
請提供採購要求，以便為您的項目準備相應的技術及商業資料。
數量及目的地
請提供所需數量及目的地市場，以界定商業供應需求。
配方及生產
請提供預定劑型及開發階段，以便在實際情境中審視物料要求。
文件及報價
請說明採購審核所需的技術文件、包裝資料及商業細節。